Angion Biomedica Corp Revenue and Competitors

Uniondale, NY USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Angion Biomedica Corp's estimated annual revenue is currently $2.8M per year.(i)
  • Angion Biomedica Corp's estimated revenue per employee is $123,043
  • Angion Biomedica Corp's current valuation is $67.6M. (January 2022)

Employee Data

  • Angion Biomedica Corp has 23 Employees.(i)
  • Angion Biomedica Corp grew their employee count by 5% last year.

Angion Biomedica Corp's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, Pharmacovigilance and Risk ManagementReveal Email/Phone
3
VP BiometricsReveal Email/Phone
4
SVP and General CounselReveal Email/Phone
5
Director, Medical WritingReveal Email/Phone
6
Assistant Director Chemistry and Safety OfficerReveal Email/Phone
7
Executive Chairman and Chief Scientific OfficerReveal Email/Phone
8
Interim Chief Financial OfficerReveal Email/Phone
9
Director, Statistical ProgrammingReveal Email/Phone
10
Clinical Trial ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Angion Biomedica Corp?

We are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Our goal is to transform the treatment paradigm for patients suffering from these potentially life-threatening conditions for which there are no approved medicines or where existing approved medicines have limitations.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.8M

Revenue (est)

5%

Employee Growth %

$67.6M

Valuation

N/A

Accelerator

Angion Biomedica Corp News

2022-04-13 - Angion Announces Participation in Upcoming Investment Conference GlobeNewswire

Angion Announces Participation in Upcoming Investment Conference GlobeNewswire

2022-03-30 - Angion Biomedica : Provides Corporate Update and Reports Full Year 2021 Financial Results - Form 8-K MarketScreener

Angion Biomedica : Provides Corporate Update and Reports Full Year 2021 Financial Results - Form 8-K MarketScreener

2022-03-22 - Angion Biomedica (NASD: ANGN) CEO Focus on Primary ... The Wall Street Transcript

Angion Biomedica (NASD: ANGN) CEO Focus on Primary ... The Wall Street Transcript

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M297%N/A
#2
$5M3050%N/A
#3
$6.4M327%N/A
#4
$7.5M333%N/A
#5
$8.3M4137%N/A